The new team members, Solenn Percelay and Noémie Spinelli, will support the organization’s commitment to excellence in humanized mouse model care and use
AAALAC endorses the use of animals to advance medicine and science in situations where there are no non-animal alternatives, but the work must be carried out in an ethical and humane way. Accreditation by AAALAC is voluntary. To succeed, organizations must demonstrate they not only meet minimum lawful standards, but also strive for excellence in animal care and use. TransCure bioServices received accreditation in June 2022.
Dr Solenn Percelay will be a crucial source of animal welfare knowledge, conducting research to improve mouse welfare through studies such as the impact of enrichment on animal behavior and stress. Dr Noémie Spinelli will join the current team of veterinarians to oversee the health of the mice, and work with customers to detect any unexpected adverse drug reactions. Both roles are crucial to improving the health and wellbeing of the mice in TransCure bioServices’ top-of-the-range animal facilities.
“Good science cannot be done without maintaining a very high standard of ethics,” says Dr Sébastien Tabruyn, General Manager and Chief Scientific Officer (CSO), TransCure bioServices. “In TransCure bioServices, we go beyond what is required by European regulations to make sure that our mice receive the highest possible care. We are thrilled that Solenn and Noémie are joining our team, as they share our vision for driving animal welfare. With their added support, our customers can be confident that they are working with partners that not only provide the cutting-edge models and technologies they need to advance their science, but who are also fully committed to animal ethics and wellbeing.”
For further information on TransCure bioServices’ AAALAC accreditation and commitment to animal welfare, please visit https://transcurebioservices.com/news/transcure-bioservices-is-aaalac-accredited/
About TransCure bioServices:
TransCure bioServices is a unique fee-for-service Contract Research Organization (CRO) with expertise in conducting research using humanized mouse models, supported by cutting edge technologies. The company offers qualified services across a range of disease models, from preliminary discussion through tailor-made protocols, experiments, and reporting. TransCure bioServices adheres to rigorous standards including AALAC accreditation and the three R’s: Replacement, Reduction, and Refinement of responsible animal use.